Highlights
- •We presented a Chinese HSP family with exon 8–17 deletions of the SPAST gene.
- •The patients with deletions of exons in the SPAST gene showed pure HSP.
- •Age at onset of the patients with exon deletion of the SPAST gene showed variations.
- •Exon deletion should be examined routinely in HSP patients.
Abstract
Hereditary spastic paraplegia (HSP) is a group of clinically and genetically heterogeneous
neurodegenerative disorders. SPG4 is the most common autosomal dominant form of HSP
subtypes and is caused by mutations of the SPAST gene. Here we reported a Chinese family with HSP caused by deletion of exons 8–17
of the SPAST gene and reviewed the clinical phenotypes of patients with exon deletion that were
reported in literatures. The patients with deletions of exons in the SPAST gene showed pure HSP, and the age at onset showed interfamily and intrafamily variations.
This study suggests that exon deletion should be examined routinely in patients who
are clinically diagnosed with HSP.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Classification of the hereditary ataxias and paraplegia.Lancet. May 1983; 1: 1151-1155
- Mutation in CPT1C associated with pure autosomal dominant spastic paraplegia.JAMA Neurol. May 2015; 72: 561-570
- Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.Nat. Genet. Nov 1999; 23: 296-303
- Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.Hum. Mutat. Aug 2002; 20: 127-132
- High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia.Neurology. Dec 2006; 67: 1926-1930
- Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.J. Med. Genet. Apr 2007; 44: 281-284
- Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia.Eur. J. Neurol. Jul 2007; 14: 809-814
- Linkage to a known gene but no mutation identified: comprehensive reanalysis of SPG4 HSP pedigrees reveals large deletions as the sole cause.Hum. Mutat. Jul 2007; 28: 739-740
- Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia.J. Neurol. Sci. Sep 2009; 284: 90-95
- Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia.Eur. J. Hum. Genet. Feb 2009; 17: 187-194
- Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia.BMC Neurol. Oct 2010; 10: 89
- Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations.J. Neurol. Neurosurg. Psychiatry. Oct 2010; 81: 1073-1078
- Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family.Neurogenetics. Feb 2011; 12: 25-31
- Spastin mutation screening in Chinese patients with pure hereditary spastic paraplegia.Parkinsonism Relat. Disord. Aug 2014; 20: 845-849
- Genetic analysis of SPG4 and SPG3A genes in a cohort of Chinese patients with hereditary spastic paraplegia.J. Neurol. Sci. Dec 2014; 347: 368-371
- High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia.BMC Neurol. Nov 2014; 4: 216
- Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM.BMC Med. Genet. Jun 2008; 9: 53
- Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia.Hum. Mol. Genet. Mar 2000; 9: 637-644
- Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia.Arch. Neurol. Jan 2004; 61: 49-55
- The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy.J. Neurol. Jan 2014; 261: 52-59
Article info
Publication history
Published online: July 03, 2015
Accepted:
July 1,
2015
Received in revised form:
June 30,
2015
Received:
June 3,
2015
Identification
Copyright
© 2015 Elsevier B.V. Published by Elsevier Inc. All rights reserved.
